Literature DB >> 7574497

Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2.

M H Gelb1, M K Jain, A M Hanel, O G Berg.   

Abstract

Interfacial enzymes operate at an organized interface such as lipid aggregates in contact with the aqueous phase. The enzyme phospholipase A2 is a well studied interfacial enzyme, and a discussion of its behavior at interfaces is the topic of this review. Knowledge gained from studies of phospholipases A2 can be applied toward the quantitative analysis of other interfacial enzymes. The kinetic analysis of these enzymes is greatly simplified if one establishes certain experimental conditions that limit the exchange of enzyme and substrate between different substrate aggregates. With such constraints, the kinetics can be analyzed in terms of classical Michaelis-Menten theory adopted for the action of enzymes at interfaces. It is also possible to describe other enzyme properties such as inhibition and substrate preferences in a meaningful way using formalism that is well known in solution-phase enzymology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574497     DOI: 10.1146/annurev.bi.64.070195.003253

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  39 in total

1.  Sterol and steryl ester regulation of phospholipase A2 from the mosquito parasite Lagenidium giganteum.

Authors:  J L Kerwin; J K MacKichan; M J Semon; A M Wiens; C C DeRose; J J Torvik
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

2.  High specificity of human secretory class II phospholipase A2 for phosphatidic acid.

Authors:  Y Snitko; E T Yoon; W Cho
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.

Authors:  S A Tatulian
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

4.  Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity.

Authors:  Kamen S Koumanov; Albena B Momchilova; Peter J Quinn; Claude Wolf
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

5.  Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).

Authors:  J Polgár; E M Magnenat; M C Peitsch; T N Wells; K J Clemetson
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

6.  Zero-order interfacial enzymatic degradation of phospholipid tubules.

Authors:  P A Carlson; M H Gelb; P Yager
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

7.  Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.

Authors:  Marina Markova; Revati A Koratkar; Karen A Silverman; Vincent E Sollars; Melina MacPhee-Pellini; Rhonda Walters; Juan P Palazzo; Arthur M Buchberg; Linda D Siracusa; Steven A Farber
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

8.  Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.

Authors:  Lauren P Saunders; Amy Ouellette; Russ Bandle; William Chozen Chang; Hongwen Zhou; Raj N Misra; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

9.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

Review 10.  Electrodes modified with lipid membranes to study quinone oxidoreductases.

Authors:  Sophie A Weiss; Lars J C Jeuken
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.